Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: A population-based study

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 1, 2009, Pages 68-73

  Lomtadze, Nino ^a,b   Aspindzelashvili, R ^a   Janjgava, M ^a   Mirtskhulava, V ^a,b   Wright, A ^c   Blumberg, H M ^b   Salakaia, A ^a  

^a National Centre for Tuberculosis and Lung Diseases   (Georgia)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Drug Resistance Survey; Georgia; MDR TB; Multidrug resistant tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ACID FAST BACTERIUM; ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CHILD; CONTROLLED STUDY; DISEASE CONTROL; DISEASE COURSE; FEMALE; GEORGIA (REPUBLIC); HUMAN; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEWBORN; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RISK FACTOR; SEX;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; GEORGIA (REPUBLIC); HUMANS; MALE; MIDDLE AGED; PREVALENCE; RECURRENCE; RISK FACTORS; SEX FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 58149398272     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Schwalbe N, Harrington P. HIV and tuberculosis in the former Soviet Union. Lancet 2002; 360 (Suppl 1): S19-S20.
2. Weinstock D M, Hahn O, Wittkamp M, Sepkowitz K A, Khechinashvili G, Blumberg H M. Risk for tuberculosis infection among internally displaced persons in the Republic of Georgia. Int J Tuberc Lung Dis 2001; 5: 164-169.
3. Zalesky R, Abdullajev F, Khechinashvili G, et al. Tuberculosis control in the Caucasus: successes and constraints in DOTS implementation. Int J Tuberc Lung Dis 1999; 3: 394-401.
4. Richards D M T, Parris J, Kourbatova E, et al. High prevalence of hepatitis C virus but not HIV co-infection among patients with tuberculosis in Georgia. Int J Tuberc Lung Dis 2006; 10: 396-401.
5. Salakaia A. Georgia Tuberculosis National Programme 2005 report. Tbilisi, Georgia: Georgia Tuberculosis National Programme, 2006.
6. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/STB/2006.371. Geneva, Switzerland: WHO, 2006.
7. Aerts A, Habouzit M, Mschiladze L, et al. Pulmonary tuberculosis in prisons of the ex-USSR state Georgia: results of a nationwide prevalence survey among sentenced inmates. Int J Tuberc Lung Dis 2000; 4: 1104-1110.
8. Mdivani N, Zangaladze E, Volkova N, et al. High prevalence of multidrug resistant tuberculosis in Georgia. Int J Infect Dis 2008; 12: 635-644.
9. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. WHO/CDS/CSR/RMD/2003. Geneva, Switzerland: WHO, 2003.
10. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2005. WHO/HTM/TB/2005.349. Geneva, Switzerland: WHO, 2005.
11. World Health Organization. Identification of tuberculosis suspects. Managing TB at the raion level. WHO/CDS/TB/2002.310. Geneva, Switzerland: WHO, 2003.
12. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 3rd ed. WHO/CDS/TB/2003.313. Geneva, Switzerland: WHO, 2003.
13. Crofton J C P, Maher D. Guidelines for the management of drug-resistant tuberculosis. WHO/TB/96.210 (Rev. 1). Geneva, Switzerland: World Health Organization, 1997.
14. World Health Organization. Guidelines on standard operating procedures for microbiology. Chapter 17: tuberculosis. Geneva, Switzerland: WHO, 2006.
15. Espinal M A, Kim S J, Suarez P G, et al. Standard short-course chemotherapy for drug-resistant tuberculosis - treatment outcomes in 6 countries. JAMA 2000; 283: 2537-2545.
16. World Health Organization. Anti-tuberculosis drug resistance in the world. Third global report. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 1999-2002. WHO/HTM/TB/2004.343. Geneva, Switzerland: WHO, 2004.
17. Pablos-Mendez A, Raviglione M C, Laszlo A, et al. Global surveillance for anti-tuberculosis drug resistance, 1994-1997. N Engl J Med 1998; 338: 1641-1649.
18. Faustini A, Hall A J, Perucci C A. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 2006; 61: 158-163.
19. Espinal M A L K, Camacho M, Fusheng Z, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 2001; 5: 887-893.
20. World Health Organization. Global plans to stop TB 2006-2015: actions for life towards a world free of tuberculosis. Geneva, Switzerland: WHO, 2006.
21. Cox H, Orozco J D, Male R, et al. Multidrug-resistant tuberculosis in Central Asia. Emerg Infect Dis 2004; 10: 865-872.